83 related articles for article (PubMed ID: 26483198)
1. Synthesis and biological evaluation of 5-(fluoro-substituted-6-methylpyridin-2-yl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)imidazoles as inhibitors of transforming growth factor-β type I receptor kinase.
Krishnaiah M; Jin CH; Sheen YY; Kim DK
Bioorg Med Chem Lett; 2015 Nov; 25(22):5228-31. PubMed ID: 26483198
[TBL] [Abstract][Full Text] [Related]
2. Discovery of N-((4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1H-imidazol-2-yl)methyl)-2-fluoroaniline (EW-7197): a highly potent, selective, and orally bioavailable inhibitor of TGF-β type I receptor kinase as cancer immunotherapeutic/antifibrotic agent.
Jin CH; Krishnaiah M; Sreenu D; Subrahmanyam VB; Rao KS; Lee HJ; Park SJ; Park HJ; Lee K; Sheen YY; Kim DK
J Med Chem; 2014 May; 57(10):4213-38. PubMed ID: 24786585
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of the epithelial-to- mesenchymal inhibitory activity of indazole-derived imidazoles as dual ALK5/p38α MAP inhibitors.
Liu YY; Guo Z; Wang JY; Wang HM; Da Qi J; Ma J; Piao HR; Jin CH; Jin X
Eur J Med Chem; 2021 Apr; 216():113311. PubMed ID: 33677350
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of novel benzo[c][1,2,5]thiadiazol-5-yl and thieno[3,2-c]- pyridin-2-yl imidazole derivatives as ALK5 inhibitors.
Guo Z; Song X; Zhao LM; Piao MG; Quan J; Piao HR; Jin CH
Bioorg Med Chem Lett; 2019 Aug; 29(16):2070-2075. PubMed ID: 31303386
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and antifibrosis evaluation of 4-(benzo-[c][1,2,5]thiadiazol-5-yl)-3(5)-(6-methyl- pyridin-2-yl)pyrazole and 3(5)-(6-methylpyridin- 2-yl)-4-(thieno-[3,2,-c]pyridin-2-yl)pyrazole derivatives.
Zhu WJ; Cui BW; Wang HM; Nan JX; Piao HR; Lian LH; Jin CH
Eur J Med Chem; 2019 Oct; 180():15-27. PubMed ID: 31299584
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and optimization of 7-substituted-pyrazolo[4,3-b]pyridine ALK5 (activin receptor-like kinase 5) inhibitors.
Sabat M; Wang H; Scorah N; Lawson JD; Atienza J; Kamran R; Hixon MS; Dougan DR
Bioorg Med Chem Lett; 2017 May; 27(9):1955-1961. PubMed ID: 28359790
[TBL] [Abstract][Full Text] [Related]
7. Novel ALK5 inhibitor TP0427736 reduces TGF-β induced growth inhibition in human outer root sheath cells and elongates anagen phase in mouse hair follicles.
Naruse T; Aoki M; Fujimoto N; Arase S; Oura H; Ueda Y; Ikeda A
Pharmacol Rep; 2017 Jun; 69(3):485-491. PubMed ID: 28324846
[TBL] [Abstract][Full Text] [Related]
8. ALK5 kinase inhibitory activity and synthesis of 2,3,4-substituted 5,5-dimethyl-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazoles.
Řezníčková E; Tenora L; Pospíšilová P; Galeta J; Jorda R; Berka K; Majer P; Potáček M; Kryštof V
Eur J Med Chem; 2017 Feb; 127():632-642. PubMed ID: 28135685
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, p38α MAP kinase inhibition, anti-inflammatory activity, and molecular docking studies of 1,2,4-triazole-based benzothiazole-2-amines.
Tariq S; Alam O; Amir M
Arch Pharm (Weinheim); 2018 Apr; 351(3-4):e1700304. PubMed ID: 29611883
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, biological evaluation and molecular modelling of 2,4-disubstituted-5-(6-alkylpyridin-2-yl)-1
Park MS; Park HJ; An YJ; Choi JH; Cha G; Lee HJ; Park SJ; Dewang PM; Kim DK
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):702-712. PubMed ID: 32164459
[TBL] [Abstract][Full Text] [Related]
11. EW-7197, a novel ALK-5 kinase inhibitor, potently inhibits breast to lung metastasis.
Son JY; Park SY; Kim SJ; Lee SJ; Park SA; Kim MJ; Kim SW; Kim DK; Nam JS; Sheen YY
Mol Cancer Ther; 2014 Jul; 13(7):1704-16. PubMed ID: 24817629
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and anti-inflammatory activity of imidazol-5-yl pyridine derivatives as p38α/MAPK14 inhibitor.
Ali EMH; Abdel-Maksoud MS; Hassan RM; Mersal KI; Ammar UM; Se-In C; He-Soo H; Kim HK; Lee A; Lee KT; Oh CH
Bioorg Med Chem; 2021 Feb; 31():115969. PubMed ID: 33422910
[TBL] [Abstract][Full Text] [Related]
13. An optimized and versatile synthesis to pyridinylimidazole-type p38α mitogen activated protein kinase inhibitors.
El-Gokha A; Laufer SA; Koch P
Org Biomol Chem; 2015 Nov; 13(43):10699-704. PubMed ID: 26351018
[TBL] [Abstract][Full Text] [Related]
14. Discovery of 7-methoxy-6-[4-(4-methyl-1,3-thiazol-2-yl)-1H-imidazol-5-yl]-1,3-benzothiazole (TASP0382088): a potent and selective transforming growth factor-β type I receptor inhibitor as a topical drug for alopecia.
Amada H; Asanuma H; Koami T; Okada A; Endo M; Ueda Y; Naruse T; Ikeda A
Chem Pharm Bull (Tokyo); 2013; 61(3):286-91. PubMed ID: 23449197
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of N-(3-fluorobenzyl)-4-(1-(methyl-d
Kang BN; Kang HJ; Kim S; Lee J; Lee J; Jeong HJ; Jeon S; Shin Y; Yoon C; Han C; Seo J; Yun J
Bioorg Med Chem Lett; 2023 Apr; 85():129205. PubMed ID: 36858078
[TBL] [Abstract][Full Text] [Related]
16. TGF-beta inhibits CYP17 transcription in H295R cells acting via activin receptor-like kinase 5.
Derebecka-Holysz N; Lehmann TP; Holysz M; Trzeciak WH
Endocr Res; 2009; 34(3):68-79. PubMed ID: 19701832
[TBL] [Abstract][Full Text] [Related]
17. A Diverse and Versatile Regiospecific Synthesis of Tetrasubstituted Alkylsulfanylimidazoles as p38α Mitogen-Activated Protein Kinase Inhibitors.
Ansideri F; Andreev S; Kuhn A; Albrecht W; Laufer SA; Koch P
Molecules; 2018 Jan; 23(1):. PubMed ID: 29361698
[TBL] [Abstract][Full Text] [Related]
18. Application of Pd-Catalyzed Cross-Coupling Reactions in the Synthesis of 5,5-Dimethyl-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazoles that Inhibit ALK5 Kinase.
Tenora L; Galeta J; Řezníčková E; Kryštof V; Potáček M
J Org Chem; 2016 Dec; 81(23):11841-11856. PubMed ID: 27934472
[TBL] [Abstract][Full Text] [Related]
19. Hit generation and exploration: imidazo[4,5-b]pyridine derivatives as inhibitors of Aurora kinases.
Bavetsias V; Sun C; Bouloc N; Reynisson J; Workman P; Linardopoulos S; McDonald E
Bioorg Med Chem Lett; 2007 Dec; 17(23):6567-71. PubMed ID: 17933533
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and tissue distribution of 3-((5-(6-methylpyridin-2-yl)-4-(quinoxalin-6-yl)-1H-imidazol-2-yl)methyl)benzamide; a novel ALK5 inhibitor and a potential anti-fibrosis drug.
Kim YW; Kim YK; Lee JY; Chang KT; Lee HJ; Kim DK; Sheen YY
Xenobiotica; 2008 Mar; 38(3):325-39. PubMed ID: 18274960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
